POTENTIALS FOR USE OF OMEZ D IN THE TREATMENT OF FUNCTIONAL DYSPEPSIA
- 作者: Bulgakov S.A.1, Bulgakov S1
-
隶属关系:
- 期: 编号 20 (2010)
- 页面: 52-55
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278727
- ID: 278727
如何引用文章
全文:
详细
It examines new possibility of functional dyspepsia treatment, its ulcerous and dyskinetic variants. It was worked out fixed combinations of remedies, combining in one capsule prokinetic domperidone and proton pump inhibitor omeprazol. Such combined preparation is Omez D, which normalizes motor function of digestive tract upper part and inhibitor secretion of hydrochloric acid in stomach. It positively influences on reduction of pain syndrome in epigastrium and dyspepsia presentations, which are typical for functional dyspepsia. It is presented indications of Omez D, schemes and intake.
参考
- Talley NJ, Stanghelinni V, Heading RC, et al. Functional gastrointestinal disorders. Gut 1999;45(II):1137-42.
- Рациональная фармакотерапия заболеваний органов пищеварения. Руководство для практикующих врачей / Под ред. Ивашкина В.Т. М., 2003. С. 1045.
- Шептулин А.А. Хронический гастрит и функциональная диспепсия: есть ли выход из тупика? (размышления, навеянные Римскими критериями III) // Росс. журнал гастроэнтер., гепатол., колопроктол. 2010. № 2. С. 84-8.
- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130(5):1377-90.
- Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130(5):1466-79.
- Moayyedi P, Delaney BC, Valik N, et al. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004;127:1329-37.
- Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;2:CD002096.
- Moayyedi P, Soo S, Deeks J, et al. Systemic review:Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003;17: 1215-27.
- Brogden RN, Carmine AA, Heel RC, et al. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic Drugs 1982;24:360-400.
- Васильев Ю.В. Терапия неязвенной функциональной диспепсии // РМЖ 2002. № 2. С. 35-8.
- Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender difference in Epidemiology, Pathophysiologic mechanisms. Clinical presentation and management Am J Gastroenterol 2006;101:644-53.
- Yi-fan Zhang, Xiao-yan Chen, Xiao-jian Dai, et al. Influence of pharmacokinetics of domperidone given as free base and maleate salt in healthy Chinese patients. Acta Pharmacol Sin 2007;28(8):1243-46.
- Holmann G, Talley NJ, Liebregts T, et al. A Placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832-40.
补充文件
